Drawing for BOTOX ONE

USPTO serial 97115781

BOTOX ONE

Reviewed by CopyMark Law Group

Reg. 7243678Status 700Registered
Filing date
Status date
Registration date
Dec 12, 2023
Examiner
DONEGAN, DANIEL P
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with BOTOX ONE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
035Providing business information about the administration of patient reimbursement programs designed to assist patients regarding medical treatment payment plan options; assistance to patients regarding treatment payment plan options, namely, business administration of patient reimbursement programs; providing a website via a global computer network featuring consumer information and comprehensive content being consumer product information in the fields of neurology, dermatology and urology; distribution of samples for trial purposes in the field of neurology, dermatology and urology; promoting healthcare professionals' awareness of the benefits of botulinum toxin and dissemination of advertisements and consumer product information relating to botulinum toxin via print, audio, video, digital, on-line medium, and electronic mailACTIVEJan 19, 2019
036Medical advisory services regarding treatment payment plan reimbursement of a portion of a patient's out-of-pocket expenses, namely, providing financial administration of patient reimbursement programs; assistance to patients regarding treatment payment plan options, namely, financial administration of patient reimbursement programs; providing financial information about the administration of patient reimbursement programs designed to assist patients regarding medical treatment payment plan optionsACTIVEJan 19, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 12, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 12, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 9, 2023SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Nov 8, 2023CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Nov 8, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Nov 8, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 8, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 8, 2023SNEASU-EXAMINER'S AMENDMENT WRITTEN—
Nov 1, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 1, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 1, 2023CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 16, 2023SUPCSTATEMENT OF USE PROCESSING COMPLETE—
May 10, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 21, 2023IUAFUSE AMENDMENT FILED—
Apr 21, 2023EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Nov 29, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 4, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 4, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 14, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 1, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 30, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 29, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 29, 2022ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jun 7, 2022GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jun 7, 2022GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 7, 2022CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 16, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 16, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 16, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 29, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 29, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 29, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 24, 2021DOCKASSIGNED TO EXAMINER—
Nov 18, 2021MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Nov 17, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—

Frequently asked questions

Related guidance